Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Preparation of HIF-2alpha small-molecule inhibitor and application thereof

A small molecule inhibitor, HIF-2 technology, applied in the field of medicine to achieve the effects of reduced toxicity, broad anti-cancer spectrum and good inhibitory effect

Active Publication Date: 2021-06-18
中国医科大学
View PDF6 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, studies have shown that the effective rate of treating human glioma with TMZ is about 45%.
At present, there is no HIF-2α inhibitor on the market, only the small molecule P2977, which can target and inhibit pVHL-deficient kidney cancer cells, is currently in phase II clinical trials, and there is no HIF-2α that can be used for other tumors such as glioma. 2α inhibitor reports

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation of HIF-2alpha small-molecule inhibitor and application thereof
  • Preparation of HIF-2alpha small-molecule inhibitor and application thereof
  • Preparation of HIF-2alpha small-molecule inhibitor and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0099] Example 1 1-([1,2,4]Triazolo[4,3-a]pyrazin-8-yl)-N-benzyl-N-(furan-2-ylmethyl)methanamine ( Preparation of A1).

[0100] Step 1. Dissolve 3-bromo-2-chloropyrimidine (10g, 0.052mol) in toluene (200ml), cool down to -65°C, add DMF (dimethylformamide) (6.2ml, 0.08mol) dropwise , After dropping, n-butyllithium (1.57M solution in n-hexane; 51 mL, 0.08 mol) was added dropwise. After stirring for 20 minutes, the reaction was terminated with 1N hydrochloric acid, then the reaction solution was extracted with ethyl acetate, several layers were washed with water, dried over anhydrous magnesium sulfate, filtered, and concentrated to dryness to obtain the product (intermediate a) without further purification. in the next step.

[0101] Step 2. Sodium borohydride (2 g, 0.052 mol) was slowly added in batches to the solution of intermediate a dissolved in ethanol (30 mL) at room temperature, and stirred for 30 minutes after the addition. After quenching the reaction with 36% glacia...

Embodiment 2

[0107] Example 2 1-([1,2,4]Triazolo[4,3-a]pyrazin-8-yl)-N-(4-fluorobenzyl)-N-(furan-2-ylmethane yl) methylamine (A2).

[0108] The preparation method is the same as that of Example 1, ESI-MS m / z: 337.36; 1 H-NMR (400MHz, DMSO-d 6 )δ9.13(s,1H),8.36(d,J=2.7Hz,1H),7.68(d,J=2.7Hz,1H),7.44(dd,J=0.32Hz,2H),7.36(d, J=4.3Hz, 1H), 7.07(t, 2H), 6.52(d, J=0.88Hz, 1H), 6.30(t, J=0.88Hz, J=4.3Hz, 1H), 3.99(s, 2H) , 3.82(s, 2H), 3.54(s, 2H).

Embodiment 3

[0109] Example 3 1-([1,2,4]Triazolo[4,3-a]pyrazin-8-yl)-N-(3-bromophenyl)-N-(furan-2-ylmethane yl) methylamine (A3).

[0110] The preparation method is the same as that of Example 1, ESI-MS m / z: 398.26.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of medicines, and relates to an HIF-2 alpha small-molecule inhibitor as well as a preparation method and an application thereof. The HIF-2alpha small-molecule inhibitor is a compound as shown in a structural general formula I and a stereoisomer, a pharmaceutically acceptable salt, a hydrate, a solvate or a prodrug thereof. According to the invention, molecular simulation drug design software MOE is used for screening and molecular docking of pharmacophores, according to a final docking dominant structure and an isosteric principle, a series of compounds are designed and synthesized, and an in-vitro anti-tumor activity screening test shows that the compounds have anti-tumor activity. The HIF-2 alpha small-molecule inhibitor provided by the invention has a relatively good application prospect in the aspect of preventing or treating cancers, particularly glioma.

Description

technical field [0001] The invention belongs to the technical field of medicine, and relates to a class of HIF-2α small molecule inhibitors and a preparation method and application thereof. Background technique [0002] Cancer is a malignant tumor, generally normal cells in the body have abnormal cell differentiation and proliferation due to external stimuli, grow out of control, and have invasive and metastatic properties. Glioma is the abbreviation of glioma (Gliomas), also known as gliocytoma, which is the most common primary central nervous system tumor in the brain. half. Temozolomide (TMZ) is an oral alkylating agent that can cross the blood-brain barrier and reach the lesions directly. It is one of the first-line chemotherapy drugs for the clinical treatment of glioma. However, studies have shown that the effective rate of treating human gliomas with TMZ is about 45%. Among them, the resistance of gliomas to TMZ is the main reason for the failure of chemotherapy. ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D487/04A61P35/00A61K31/4985A61K31/506
CPCC07D487/04A61P35/00
Inventor 颜媛媛朴浩哲祝妍
Owner 中国医科大学
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com